[{"uuid": "47612a9a-7998-3287-a5f5-15ff61271066", "title": "Biogen Stock Down on Regulatory Update in the EU for Alzheimer's Drug", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/biogen-stock-down-regulatory-eu-143100317.html", "providerPublishTime": 1738593060, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/tsWYAfY6SuBuC3962BZpAA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7d0a870e8718511cdf6e5d72d84220a5", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/C3VWzmlS5f5LmkxlbEr6qA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/7d0a870e8718511cdf6e5d72d84220a5", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BIIB"]}, {"uuid": "c104f5da-0221-3390-b8c6-4de197306aaa", "title": "Why Are Analysts Bullish on Biogen Inc. (BIIB) Now?", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/why-analysts-bullish-biogen-inc-131212786.html", "providerPublishTime": 1738501932, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/kwPLJDk7Luq5fNkaxqHOIQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/8095fdfd16ed3bef236befbd7ca2428c", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/_UXVmt0oLf4cYEz80SeE4Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/8095fdfd16ed3bef236befbd7ca2428c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BIIB", "^GSPC"]}, {"uuid": "17236d9e-07c9-3ecb-9be0-a28f401d51fe", "title": "Biogen, Eisai Say EU Panel Set to Discuss Additional Safety Data on Lecanemab", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/biogen-eisai-eu-panel-set-130955866.html", "providerPublishTime": 1738328995, "type": "STORY", "relatedTickers": ["BIIB"]}, {"uuid": "e0b647ee-39eb-3331-821d-af9bf175d1cc", "title": "Update on Regulatory Review of Lecanemab for Early Alzheimer\u2019s Disease in the European Union", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/regulatory-review-lecanemab-early-alzheimer-113000680.html", "providerPublishTime": 1738323000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Usad_0vByWWo5BOAvLTZHg--~B/aD0yOTA7dz04NjU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d8db71a830aa632e702f24ebd736c00d", "width": 865, "height": 290, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/0J7xwYxnhrAhYkLIdQYxNA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/d8db71a830aa632e702f24ebd736c00d", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BIIB"]}, {"uuid": "814ae39f-c481-3d60-8b95-5b2a5d4c3173", "title": "Will Biogen (BIIB) Beat Estimates Again in Its Next Earnings Report?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/biogen-biib-beat-estimates-again-171012358.html", "providerPublishTime": 1738170612, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/UYup8AGIrn99rMsHiTllqA--~B/aD04NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee", "width": 900, "height": 876, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/XhCCCM1n.mhdk3ZYrtuYVA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BIIB"]}, {"uuid": "afe17d22-d20c-3927-9cfd-3ddbf8007209", "title": "The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen, Cytokinetics and Akero Therapeutics", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-sage-145500682.html", "providerPublishTime": 1738248900, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/LQ_ww2eZjlMvbiXmaf.EDA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/H5j0X5VJ3peIo6cA0ud3Qg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/9d995582658bf49e50317a8120603e3e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BIIB", "SAGE", "AKRO", "CYTK"]}, {"uuid": "63a44822-bad7-3bb9-94c3-c4469ebcaccb", "title": "BMO Capital Adjusts Price Target on Biogen to $156 From $164, Keeps Market Perform Rating", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/bmo-capital-adjusts-price-target-142006423.html", "providerPublishTime": 1738160406, "type": "STORY", "relatedTickers": ["BIIB"]}, {"uuid": "645cabf6-5045-38d1-921f-f98f3b586442", "title": "Leerink Partners Adjusts Biogen Price Target to $260 From $290, Maintains Outperform Rating", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/leerink-partners-adjusts-biogen-price-133437871.html", "providerPublishTime": 1738157677, "type": "STORY", "relatedTickers": ["BIIB"]}, {"uuid": "6640d076-c220-3617-aab9-38b207590a8b", "title": "Biotech Stock Roundup: SAGE Up on Declining BIIB's Offer, CYTK, AKRO Up on Updates", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/biotech-stock-roundup-sage-declining-170200168.html", "providerPublishTime": 1738170120, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/.UMP6LIbiG0Pb3tKR9RYYw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1566882a22938942efee3e7508e93e96", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/GGbbFeHcXoThOctYgnQqXQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/1566882a22938942efee3e7508e93e96", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["SAGE", "BIIB", "CYTK", "AKRO"]}, {"uuid": "2171d3e1-1903-3e54-9233-653b903d5762", "title": "Citigroup Adjusts Price Target on Biogen to $160 From $190, Maintains Neutral Rating", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/citigroup-adjusts-price-target-biogen-112317007.html", "providerPublishTime": 1738063397, "type": "STORY", "relatedTickers": ["BIIB"]}, {"uuid": "f9939889-9aae-3843-95a0-c1d26c30f8d7", "title": "BIIB Secures FDA Nod for Monthly Maintenance Dosing of Alzheimer's Drug", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/biib-secures-fda-nod-monthly-140500153.html", "providerPublishTime": 1737986700, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/HtLR.3pPwvCu5d5IUSCWtQ--~B/aD00OTY7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7d0183f93b51892d562cc8047433f507", "width": 620, "height": 496, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/.xLB78nLV7dfM4uHwzkQqQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/7d0183f93b51892d562cc8047433f507", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BIIB", "PRTA", "LLY"]}, {"uuid": "767e8f8f-b1ad-335f-8b43-1f72fcf1ce6b", "title": "SAGE Rejects Biogen's Offer to Buy Remaining Stake, Stock Up", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/sage-rejects-biogens-offer-buy-165400180.html", "providerPublishTime": 1738083240, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/sb.6qRd7FfGt7.wCjWz2vw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/675c0ae70cb5036ad2ceb9062f13afc2", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/y6B.X5ymHvNNdOly.Nnp7w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/675c0ae70cb5036ad2ceb9062f13afc2", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["BIIB", "SAGE"]}]